Track the 前沿生物 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). The latest transaction was disclosed on 7 September 2026 (Sale). Among the most active insiders: RONGJIAN LU. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€13m
7 ops.
Sell Volume
20Σ signal
Buys n/a€13m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
500,000 shares@ CN¥136.4475100.0% of flowA股XSHGSSE:273000001118665180
7 of 7 declarations
About 前沿生物
Qianyan Biotechnology is a company focused on the research and development of biotechnology, dedicated to the development and production of innovative drugs. The company is listed on the Chinese stock market with the ticker symbol XSHG.